Selection from HEOR Bibliography
| Search criteria | ||||
| Saudi Arabia |
||||
| A budget impact analysis of anti-inhibitor coagulant complex use in pediatric hemophilia A patients with inhibitors across kingdom of Saudi Arabia | ||||
| Al Jedai A1, AL-Mudaiheem H1, Al daamah S2, Al kasim F3, Wasri A4, Shaheen N5, Dawood E6, El-Hamaidi I7, Mohamed O8 | ||||
| 1Ministry of Health, Riyadh, NJ, USA, 2Ministry of Health, Damam, Saudi Arabia, 3Ministry of Health, Riyadh, Saudi Arabia, 4Ministry of National Guards, Jeddah, Saudi Arabia, 5King Faisal Specialized Hospitals, Damam, Saudi Arabia, 6Ministry of Health, Mekkah, Saudi Arabia, 7Ministry of National Guards, Riyadh, Saudi Arabia, 8IQVIA, Dubai, DU, United Arab Emirates | ||||
| 2019-11, ISPOR Europe 2019, Copenhagen, Denmark |
||||
| , Poster | ||||
| , Saudi Arabia | ||||
| Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/96011 | ||||
| Condition | Year | Language | Analysis type | |
| , Hematology, Rare disease | 2019 | English | , Budget impact | |
| Cost of inflammatory bowel disease management in the kingdom of Saudi Arabia | ||||
| Al Jedai A1, AL-Mudaiheem H1, Haines A2, Mosli M3, Albogami M4, Al-jaroudi F5, Alsaqa'aby M6, Awad N7, Mohamed O8 | ||||
| 1Ministry of Health, Riyadh, NJ, USA, 2Toronto University, Toronto, ON, Canada, 3King Abdulaziz University, Jeddah, Saudi Arabia, 4Ministry of Health, Damam, Saudi Arabia, 5King Fahad Specialist Hospital, Damam, Saudi Arabia, 6King Faisal Specialized Hospital and Research Center, Riyadh, Saudi Arabia, 7IQVIA, Dubai, United Arab Emirates, 8IQVIA, Dubai, DU, United Arab Emirates | ||||
| 2019-11, ISPOR Europe 2019, Copenhagen, Denmark |
||||
| , Poster | ||||
| , Saudi Arabia | ||||
| Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/97718 | ||||
| Condition | Year | Language | Analysis type | |
| , Gastrointestinal disorders | 2019 | English | , Budget impact, Literature Review | |
| THE COST OF STIGMA ASSOCIATED WITH HIV- A COST-CONSEQUENCE ANALYSIS TO EVALUATE HIV TESTING AND PREVENTION INTERVENTIONS IN KSA | ||||
| Filemban S1, Elrashied S1, Assiri A1, Hakawi A1, Snehanshu S2, Mansour E3, Vemer P4, Awad N5 | ||||
| 1Ministry of Health, Riyadh, Saudi Arabia, 2Gilead Sciences Middle East, Dubai Health Care City, United Arab Emirates, 3Gilead, Dubai, United Arab Emirates, 4Groningen University, Groningen, Netherlands, 5IQVIA, Dubai, United Arab Emirates | ||||
| 2019-11, ISPOR Europe 2019, Copenhagen, Denmark |
||||
| , Poster | ||||
| , Saudi Arabia | ||||
| Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3120/97847 | ||||
| Condition | Year | Language | Analysis type | |
| , HIV AIDS | 2019 | English | , Predictive analytics, Quality of life | |
| Budget Impact Analysis Of Golimumab In Adult Rheumatoid Arthritis Patients In Kingdom Of Saudi Arabia | ||||
| A. Al Jedai1, H. AL-Mudaiheem1, P. Pathak2, N. Awad2, O. Mohamed2, N. Alghanim1, W. Hussain1, A. Qamar1, T. Alama1 | ||||
| Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia | ||||
| DOI: https://doi.org/10.1016/j.jval.2019.04.087 |
||||
| , Article | ||||
| , Saudi Arabia | ||||
| Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)30279-7/fulltext | ||||
| Condition | Year | Language | Analysis type | |
| , Musculoskeletal disease | 2019 | English | , Budget impact, Predictive analytics | |
| Cost of treating iron deficiency anaemia (ida) with ferric carboxymaltose versus iron saccharate in heavy uterine bleeding (hub) patients in the kingdom of Saudi Arabia | ||||
| A. Alhejazi1, O. Mohamed2, M. Alhowimel1, M. Al Adham1 | ||||
| Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; IQVIA, Dubai, United Arab Emirates; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia | ||||
| DOI: https://doi.org/10.1016/j.jval.2019.04.824 |
||||
| , Article | ||||
| , Saudi Arabia | ||||
| Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)31016-2/abstract | ||||
| Condition | Year | Language | Analysis type | |
| , Hematology, Womens Health | 2019 | English | , Budget impact, Predictive analytics | |
| FINANCIAL IMPACT OF INTRODUCING SC TRASTUZUMAB (HERCEPTIN) VERSUS CURRENTLY USED IV TRASTUZUMAB (HERCEPTIN) ON THE BUDGETS OF DIFFERENT HOSPITALS ACROSS KINGDOM OF SAUDI ARABIA (KSA) | ||||
| AL-Tweigeri T1, Al-Shihri A2, Abdelhafeez N2, Ali A3, Zekri J4, Al Mansour M5, Al-gahmi A6, Ansari J7, Elbahaei A8, F Husseiny8, Awad N9, Safwat M9, Goyal R10 | ||||
| 1King Faisal Specialist Hospital, Riyadh, Kingdom of Saudi Arabia (KSA), 2King Fahad National Guard Hospital, Riyadh, Saudi Arabia and 9QuintilesIMS, Dubai; 10QuintilesIMS, India | ||||
| ISPOR 20th European conference, 4-8 November, 2017 |
||||
| , Abstract | ||||
| , Saudi Arabia | ||||
| Abstract: https://ispor.confex.com/ispor/euro20/research/papers/index.cgi?username=78109&password=956822 | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2017 | English | , Budget impact, Clinical setting: hospital, Survey research | |
| Direct medical costs of diabetes-related complications in Saudi Arabia | ||||
| 1. Hnoosh A IMS Health, HEOR, London, UK 2. Vega-Hernández G IMS Health, HEOR, London, UK 3. Jugrin A IMS Health, HEOR, London, UK 4. Todorova L Novo Nordisk International Operations, Zürich, Switzerland | ||||
| IMS Health HEOR and Novo Nordisk International Operations, Zurich | ||||
| ISPOR 17th Annual International Meeting, Washington, USA |
||||
| , Conference, Poster | ||||
| , Saudi Arabia | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2012 | English | , Literature Review | |
| Type II diabetes cost of illness study | ||||
| S. Babineaux1, W. Fakhoury2, A. McDonell3, R. Kotchie3, M. Ali4. | ||||
| 1Eli Lilly and Company, Global Health Outcomes, Indianapolis IN, USA. 2Eli Lilly and Company, Global Health Outcomes, Erl Wood, United Kingdom. 3IMS Health, UK, London, United Kingdom. 4IMS Health, Saudi Arabia, Riyadh, Saudi Arabia. | ||||
| World Diabetes Congress December 2011, Dubai, UAE |
||||
| , Conference, Poster | ||||
| , Saudi Arabia | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2011 | English | , Literature Review | |
| Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia | ||||
| Mohammed Ali 1 , Jeremy White 2 , Chen-Hui Lee 2 , James L Palmer 3 , Jayne Smith-Palmer 3 , Walid Fakhoury 4 , William J Valentine 3 | ||||
| 1 IMS Health, Riyadh, Saudi Arabia 2 Novo Nordisk International Operations A/S, Zurich, Switzerland 3 IMS Health, Basel, Switzerland 4 IMS Health, London, UK | ||||
| Journal of Medical Economics 2008; 11: 651–670 |
||||
| , Abstract | ||||
| , Saudi Arabia | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2008 | English | , Cost analysis | |